Clinical Trial: A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07887867) titled 'A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies' on Sept. 29.

Brief Summary: The purpose of this observational study is to learn about the effects of the study medicine (called abrocitinib) for the treatment of severe atopic dermatitis in people that were moved from previous novel therapies, known as "advanced" therapies.

Atopic dermatitis is a long-lasting skin condition that causes the skin to become inflamed, dry, and itchy.

This study is seeking participants who:

* are 18 years of age or older;

* have severe atopic dermatitis;

* have previo...